Buttner Mark J MJ

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Identification by ChIP-Seq of the binding sites of the extracytoplasmic function (ECF) sigma factor SigE in the genome of Streptomyces coelicolor A3(2) M600.

SigE is a sigma factor found in Streptomyces species and is the key regulator of cell envelope stress response in Streptomyces coelicolor. This ChIP-Seq experiment was carried out to determine the binding sites of SigE under conditions of cell envelope stress induced by 10 ug / ml vancomycin for 30...

ORGANISM(S): Streptomyces coelicolor A3(2)

2019-04-24 | E-MTAB-7827 | biostudies-arrayexpress

Transcriptional profiling of the sigma factor sigE deletion mutant of Streptomyces coelicolor (J2130) at 0, 30, 60 and 90 minutes after treatment with sub-lethal concentration of vancomycin.

SigE is a sigma factor found in Streptomyces species and is the key regulator of cell envelope stress response in Streptomyces coelicolor. To determine the regulon of SigE under conditions of cell envelope stress, 10 ug / ml vancomycin was used to induce cell envelope stress in the wild type and a s...

ORGANISM(S): Streptomyces coelicolor A3(2)

2019-04-24 | E-MTAB-7814 | biostudies-arrayexpress

Blood culture practices and microbiological capacity for sepsis diagnostics in Europe (2021-2022): a cross-sectional analysis of the European Sepsis Care Survey.

Not available

S-EPMC12771334 | biostudies-literature

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.

Not available

S-EPMC7616743 | biostudies-literature

Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.

Not available

S-EPMC12274867 | biostudies-literature

Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.